Tacrolimus

What is Tacrolimus test?

Tacrolimus is an immunosuppressive drug that is used in preventing organ and tissue rejection in patients after transplantation. Tacrolimus test is a therapeutic drug monitoring (TDM) test that measures tacrolimus concentration—typically a trough sample taken just before the next dose—in EDTA whole blood to individualize dosing after transplantation and balance rejection prevention with toxicity risk.

Why consider Tacrolimus test in Alappuzha?

Tacrolimus administration requires frequent and diligent monitoring by physicians to ensure proper dosage and to limit the potential for harmful adverse effects, which can include renal damage, neurotoxicity, and other serious adverse events. 

It’s Important because

• Organ Rejection Prevention

• Toxicity Minimization

• Dosage Optimization

• Monitoring and Follow-up

• Detecting Potential Problems

• Individuals with Specific Symptoms

Who should get tested for Tacrolimus test in Alappuzha?

• Solid‑organ transplant recipients (kidney, liver, heart, lung) receiving tacrolimus, especially in the early post‑transplant period and whenever medications or clinical status change.

• Patients with suspected graft dysfunction, rejection, or tacrolimus toxicity to correlate clinical findings with drug exposure.

• Recipients starting or stopping interacting agents or at risk for food–drug interactions (e.g., grapefruit, pomelo), where levels may shift unpredictably.

More information Tacrolimus test in Alappuzha

Other Names – Tac, Tac Level, Tacrolimus, Tacrolimus level, Immunosuppressive Drug

Tacrolimus is an immunosuppressive agent used for prophylaxis of organ rejection post-transplant. Tacrolimus use is in combination with one or, most commonly, two other immunosuppressive medications. It has an application as an agent for the prevention or treatment of certain autoimmune diseases. In solid organ transplantation, it serves as the treatment of organ rejection in kidney, liver, and heart allogeneic transplants. There is also an off-label indication for the prevention of rejection in lung transplant patients.